Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 June 1978:
Vol. 200. no. 4346, pp. 1173 - 1175
DOI: 10.1126/science.418505

Articles

Science, Vol 200, Issue 4346, 1173-1175
Copyright © 1978 by American Association for the Advancement of Science


articles

Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release

V Raymond, M Beaulieu, F Labrie, and J Boissier

Prior incubation of rat anterior pituitary cells with 17beta-estradiol led to an almost complete reversal of the inhibitory effect of two dopamine agonists, dihydroergocornine and RU 24213, on both basal prolactin release and thyrotropin releasing hormone-induced prolactin release. These experiments thus demonstrate a direct interference of dopamine action by a peripheral hormone. Prolactin secretion by pituitary cells in primary culture could possibly serve as an easily accessible model of a system under dopaminergic control.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Molecular Interaction of BMP-4, TGF-{beta}, and Estrogens in Lactotrophs: Impact on the PRL Promoter.
D. Giacomini, M. Paez-Pereda, J. Stalla, G. K. Stalla, and E. Arzt (2009)
Mol. Endocrinol. 23, 1102-1114
   Abstract »    Full Text »    PDF »
Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients.
M. Ono, N. Miki, T. Kawamata, R. Makino, K. Amano, T. Seki, O. Kubo, T. Hori, and K. Takano (2008)
J. Clin. Endocrinol. Metab. 93, 4721-4727
   Abstract »    Full Text »    PDF »
Prolactin and dopamine: What is the connection? A Review Article.
P. Fitzgerald and T. G Dinan (2008)
J Psychopharmacol 22, 12-19
   Abstract »    PDF »
Estrogen Actions on Lactotroph Proliferation Are Independent of a Paracrine Interaction with Other Pituitary Cell Types: A Study Using Lactotroph-Enriched Cells.
M. Ishida, W. Takahashi, S. Itoh, S. Shimodaira, S. Maeda, and J. Arita (2007)
Endocrinology 148, 3131-3139
   Abstract »    Full Text »    PDF »
Reproductive Experience Reduces Circulating 17{beta}-Estradiol and Prolactin Levels during Proestrus and Alters Estrogen Sensitivity in Female Rats.
R. S. Bridges and E. M. Byrnes (2006)
Endocrinology 147, 2575-2582
   Abstract »    Full Text »    PDF »
Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats..
M. Bottner, J. Christoffel, H. Jarry, and W. Wuttke (2006)
J. Endocrinol. 189, 77-88
   Abstract »    Full Text »    PDF »
Dopamine, Dopamine D2 Receptor Short Isoform, Transforming Growth Factor (TGF)-{beta}1, and TGF-{beta} Type II Receptor Interact to Inhibit the Growth of Pituitary Lactotropes.
D. K. Sarkar, K. Chaturvedi, S. Oomizu, N. I. Boyadjieva, and C. P. Chen (2005)
Endocrinology 146, 4179-4188
   Abstract »    Full Text »    PDF »
Diurnal Profiles of Testosterone and Pituitary Hormones Suggest Different Mechanisms for Menstrual Disturbances in Endurance Athletes.
A. Rickenlund, M. Thoren, K. Carlstrom, B. von Schoultz, and A. L. Hirschberg (2004)
J. Clin. Endocrinol. Metab. 89, 702-707
   Abstract »    Full Text »    PDF »
Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice.
S. T. Hentges and M. J. Low (2002)
Endocrinology 143, 4536-4543
   Abstract »    Full Text »    PDF »
Expression of Estrogen Receptor Subtypes in Rat Pituitary Gland during Pregnancy and Lactation.
C. Vaillant, F. Chesnel, D. Schausi, C. Tiffoche, and M.-L. Thieulant (2002)
Endocrinology 143, 4249-4258
   Abstract »    Full Text »    PDF »
The Novel Use of Very High Doses of Cabergoline and a Combination of Testosterone and an Aromatase Inhibitor in the Treatment of a Giant Prolactinoma.
M. P. Gillam, S. Middler, D. J. Freed, and M. E. Molitch (2002)
J. Clin. Endocrinol. Metab. 87, 4447-4451
   Abstract »    Full Text »    PDF »
Prolactin: Structure, Function, and Regulation of Secretion.
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy (2000)
Physiol Rev 80, 1523-1631
   Abstract »    Full Text »    PDF »
Stage- and Region-Specific Expression of Estrogen Receptor {alpha} Isoforms during Ontogeny of the Pituitary Gland.
C. Pasqualini, D. Guivarc’h, Y. v. Boxberg, F. Nothias, J.-D. Vincent, and P. Vernier (1999)
Endocrinology 140, 2781-2789
   Abstract »    Full Text »
Effects of hormone replacement on growth hormone and prolactin exercise responses in postmenopausal women.
R. R. Kraemer, L. G. Johnson, R. Haltom, G. R. Kraemer, H. Gaines, M. Drapcho, T. Gimple, and V. D. Castracane (1998)
J Appl Physiol 84, 703-708
   Abstract »    Full Text »    PDF »
Determinants of SPontaneous Extrapyramidal Symptoms in Elderly Psychiatric Inpatients Diagnosed With Alzheimer's Disease, Major Depressive Disorder, or Psychotic Disorders.
R. A. Sweet, M. Akil, B. H. Mulsant, R. Ulrich, R. E. Pasternak, and G. S. Zubenko (1998)
J Neuropsychiatry Clin Neurosci 10, 68-77
   Abstract »    Full Text »
Role of Estrogen Receptor-{{alpha}} in the Anterior Pituitary Gland.
K. M. Scully, A. S. Gleiberman, J. Lindzey, D. B. Lubahn, K. S. Korach, and M. G. Rosenfeld (1997)
Mol. Endocrinol. 11, 674-681
   Abstract »    Full Text »
Sex Difference in Age at Onset of Schizophrenia.
A. W. Loranger (1984)
Arch Gen Psychiatry 41, 157-161
   Abstract »    PDF »
Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors.
D. Sarkar, P. Gottschall, and J Meites (1982)
Science 218, 684-686
   Abstract »    PDF »
Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979.
J. M. Kane and J. M. Smith (1982)
Arch Gen Psychiatry 39, 473-481
   Abstract »    PDF »
Calcium spike electrogenesis and other electrical activity in continuously cultured small cell carcinoma of the lung.
F. McCann, O. Pettengill, J. Cole, J. Russell, and G. Sorenson (1981)
Science 212, 1155-1157
   Abstract »    PDF »
Bromocriptine and Pituitary Disorders.
J. KELLETT and H. G. FRIESEN (1979)
Ann Intern Med 90, 980-982
   Abstract »    PDF »
Opioid peptides modulate luteinizing hormone secretion during sexual maturation.
M. Blank, A. Panerai, and H. Friesen (1979)
Science 203, 1129-1131
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)